New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
07:42 EDTSNY, POZNPOZEN plans to make future employee reductions
POZEN (POZN) said, "For 2014, the company’s areas of strategic focus are obtaining FDA approval for PA8140/PA32540, transitioning all licensed know-how relating to PA in the U.S. and fulfilling all contractual obligations to Sanofi (SNY) U.S.,completing study PA10040-102, an additional Phase 1 pharmacodynamics study; preparing the regulatory filing document for PA product candidates in the European Union, finding partners for the PA and Treximet assets in ex-U.S. territories and controlling expenses. We have made the strategic decision to not start new development programs that are not fully funded by a partner. As a result, we have reduced our staff to fifteen employees and plan to make future reductions. Our board of directors and management team continue to explore potential ways to return value to our stockholders, including future cash distributions when we accumulate surplus cash as a result of receiving milestones and royalties from our commercial partners."
News For POZN;SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
14:03 EDTSNYSanofi initiated with a Buy at HSBC
Subscribe for More Information
June 22, 2015
07:31 EDTPOZNPOZEN names Mark Glickman as Chief Commercial Officer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use